Plants produce a variety of proteinase inhibitors (PIs) that have a major function in defense against insect herbivores. In turn, insects have developed strategies to minimize the effect of dietary PIs on digestion. We have discovered that Helicoverpa larvae that survive consumption of a multidomain serine PI from Nicotiana alata (NaPI) contain high levels of a chymotrypsin that is not inhibited by NaPI. Here we describe the isolation of this NaPI-resistant chymotrypsin and an NaPI-susceptible chymotrypsin from Helicoverpa larvae, together with their corresponding cDNAs. We investigated the mechanism of resistance by mutating selected positions of the NaPIsusceptible chymotrypsin using the corresponding amino acids of the NaPI-resistant chymotrypsin. Four critical residues that conferred resistance to NaPI were identified. Molecular modeling revealed that a Phe→Leu substitution at position 37 in the chymotrypsin results in the loss of important binding contacts with NaPI. Identification of the molecular mechanisms that contribute to PI resistance in insect digestive proteases will enable us to develop better inhibitors for the control of lepidopteran species that are major agricultural pests worldwide.
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chymotrypsin mutants | inhibitor-resistant proteinase | Lepidoptera S erine peptidases from the chymotrypsin family are a large group of enzymes and, although they have a highly conserved tertiary structural fold, they have developed a range of substrate specificities critical to many biological functions, including blood coagulation and immune responses (1, 2) .
Chymotrypsin and trypsin are the major digestive serine proteases of insects from the order Lepidoptera, which comprises some of the most important agricultural pests. When ingested, protease inhibitors (PI) block protease activity and increase insect mortality by restricting the availability of essential amino acids. Mechanisms of insect resistance to PIs include the upregulation of enzymes that degrade the PIs (3, 4) , induction of enzymes that resist inactivation by PIs (5, 6) , and overproduction of enzymes to maintain normal levels of gut proteolysis (7, 8) .
As part of a strategy to develop novel insecticidal agents, we investigated the properties of a series of 6-kDa chymotrypsin and trypsin inhibitors (C1, C2, T1-T4) from Nicotiana alata (NaPI), which are members of the potato type II family of inhibitors (pin II). In our companion paper (9), we report that larvae from the major agricultural insect pest Helicoverpa punctigera that survive consumption of NaPI have high levels of an NaPI-resistant chymotrypsin. We discovered that a potato type I inhibitor (StPin1A) abolished the NaPI-resistant chymotrypsin activity and that the combination of these two PIs in artificial diets substantially stunted the growth of another agronomically important pest, H. armigera (9) . Furthermore, field-grown transgenic cotton expressing both NaPI and StPin1A showed greater insect protection over the growing season than plants expressing a single inhibitor. In the current study, we have characterized the molecular features of the NaPI-resistant chymotrypsin that prevent binding of NaPI. We cloned and expressed a series of chymotrypsin mutants that contain elements of the NaPI-resistant chymotrypsin substituted onto the NaPI-susceptible chymotrypsin framework. Finally, we tested the activity of the mutants and propose a mechanism for NaPI resistance using molecular modeling studies of the NaPI/chymotrypsin.
Results

Isolation of NaPI-Susceptible and -Resistant Chymotrypsins and Their
Encoding cDNAs. Chymotrypsins from Helicoverpa spp. that are not inhibited by the multidomain potato type II inhibitor from tobacco (NaPI) are strongly inhibited by potato type I inhibitors from potato tubers (pin I) (9) . Based on this observation, we designed an affinity-purification protocol for chymotrypsins using the immobilized chymotrypsin inhibitor domain (C1) from NaPI or pin I inhibitors. Two 24-kDa proteins were isolated and their N-terminal sequences were determined. The sequences of the C1-bound and pin I-bound proteins confirmed they were chymotrypsins, but products of different genes. DNA encoding the affinity-purified chymotrypsins was obtained using primers complementary to unique regions within the N-terminal and conserved C-terminal regions. Two clones with 72% sequence identity were obtained from an H. punctigera cDNA library (HpCh2A, GenBank accession no. AY618891.1 and HpCh5, GenBank accession no. AY618895.1) (Fig. 1) . The translated sequences of the HpCh2A and HpCh5 clones were identical to the N-terminal sequences of the affinitypurified C1-susceptible and C1-resistant chymotrypsins, respectively. Both clones encoded proteins with the features typical of serine proteases with chymotrypsin specificity, including the catalytic residues (His57, Asp102, and Ser195), conserved cysteines, and serine 189 at the base of the specificity pocket (Fig. 1) . A BLAST search in the UniProtKB/Swiss-Protein database (10) revealed that the HpCh2A protein was 96% identical to an H. armigera ortholog (GenBank accession no. Y12287), whereas HpCh5 was 95% identical to a translated H. armigera EST (GenBank accession no. EE399747).
Comparison of Chymotrypsin Sequences. HpCh2A and HpCh5 were aligned with bovine chymotrypsin (Fig. 2) to identify potential PIbinding sites within the insect chymotrypsins. We chose bovine chymotrypsin for the comparison, as it is strongly inhibited by NaPI (11) and the binding sites for other PIs are well characterized (12) (13) (14) . The PI-binding site residues include 35-40 (loop 35), 60-64 (loop 60), 96-98 (loop 96), 142-156 (loop 142), 172-176 (loop 172), and the regions that form the S1 binding pocket (residues 189-195, 214-220, and 225-228) (chymotrypsin numbering) (Fig. 2) . The insect chymotrypsins and bovine chymo- trypsin share ≈30% amino acid sequence identity. Bovine chymotrypsin has five disulfide bonds in comparison with three in the insect chymotrypsins, and some surface loops differ in size.
Recombinant Expression of an NaPI-Resistant and NaPI-Susceptible Chymotrypsin. Our first objective was to confirm that the cloned insect chymotrypsins were in fact NaPI-resistant and NaPIsusceptible. To obtain sufficient pure protein for enzyme assays, the putative NaPI-susceptible (rHpCh2A) and NaPI-resistant (rHpCh5) were expressed in Sf9 insect cells using the baculovirus expression system and purified via their N-terminal histidine tags. Activation of the chymotrypsin zymogens was achieved using bovine trypsin and the expected size shift was confirmed by SDS-PAGE (Fig. S1 ). NaPI strongly inhibited rHpCh2A but was a relatively weak inhibitor of rHpCh5 (Fig. 3) . We have previously reported that chymotrypsin activity in the gut of Helicoverpa species was strongly inhibited by StPin1A and weakly inhibited by NaPI (9) , and here we show that StPin1A is an excellent inhibitor of both recombinant chymotrypsins. To investigate which residues contribute to the resistance of HpCh5 to NaPI inhibition, a series of mutants were made by substituting amino acids from one chymotrypsin template with the corresponding residues from the other (Table 1 and Fig. 2 ). In total, one variant using the HpCh5 as template and eight variants using HpCh2A as template were produced. We first identified an arginine at position 192 (Arg192) in the NaPIresistant chymotrypsin as a likely candidate for PI resistance based on its relatively rare occurrence at this position (SI Text) and reports that, in other serine proteases, charged residues in this location prevent inhibitor binding (15, 16) . Surprisingly, when we replaced Arg192, which lies in the substrate-binding pocket (S1A) of rHpCh5 chymotrypsin (Fig. 2) , with the corresponding glutamine from the rHpCh2A sequence, the variant (Ch5[R192Q]) was more resistant to the C1 inhibitor (Fig. 4) . That is, Arg192 was not responsible for NaPI resistance. To confirm this observation, we made the corresponding variant, where the glutamine from the HpCh2A sequence was converted to an arginine (Ch2A[Q192R]).
This resulted in an enzyme with improved affinity for C1 ( Table 1) . Four of the HpCh2A variants, with substitutions outside the predicted PI-binding sites, showed no significant difference in binding of C1 compared with the wild-type enzyme (Table 1) . Five amino acid substitutions in loop 172 of HpCh2A created a variant where C1 had approximately half the binding affinity of that of the wild-type enzyme (Table 1) . Substituting four amino acids in loop 35 (positions 34, 35, 35a, and 35b) from LANF to VIDL had the most dra- Fig. 1 . Alignment of the predicted amino acid sequences of the NaPIsusceptible (HpCh2A) and NaPI-resistant (HpCh5) chymotrypsins from Helicoverpa punctigera. The HpCh2A clone encoded the full-length cDNA, including the endoplasmic reticulum signal peptide (double underline) and the activation peptide cleavage site (✪). The HpCh5 clone encoded the activation peptide and mature domain. Catalytic residues His57, Asp102, and Ser195 (#), conserved cysteines ($), and primary substrate determinant residue 189 (β) are shown. Identical residues are indicated by dark shading and similar residues are indicated by gray shading. Fig. 2 . Alignment of chymotrypsin protein sequences. Bovine chymotrypsin A and B, NaPI-susceptible chymotrypsin (HpCh2A), and NaPI-resistant chymotrypsin (HpCh5) were aligned using Clustal W. The alignment is numbered according to Greer (42) . The gray-shaded areas form surface loops (numbered) and are predicted to be involved in inhibitor binding. Catalytic residues His57, Asp102, and Ser195 are labeled (¥) and conserved cysteines ( §) are indicated. The primary substrate-binding pocket sites are numbered S1A, S1B, and S1C and the primary substrate determinant is labeled (*). Mutated residues are colored red and double-headed arrows indicate the changes made in a single variant. Fig. 3 . Activity of recombinant HpCh5 and HpCh2A in the presence of NaPI and StPin1A. Increasing concentrations of the inhibitors NaPI and StPin1A were mixed with each enzyme (100 ng) and preincubated for 10 min at 22°C. Substrate was added and residual activity was measured. Error bars represent the SEM of four individual experiments performed in duplicate. HpCh2A is more susceptible to inhibition by NaPI than HpCh5, whereas StPin1A is a potent inhibitor of both.
matic effect on C1 binding, converting HpCh2A, the NaPI-susceptible chymotrypsin, to a chymotrypsin that was as resistant to inhibition by C1 as HpCh5 (Fig. 4) .
Molecular Modeling Reveals the Contribution of Arg192 and Loop 35
to NaPI Resistance. We constructed structural models of HpCh5 and HpCh2A bound to the C1 inhibitor, based on several related crystallographic structures. The models were refined with a 50-ns molecular dynamics (md) simulation. The final chymotrypsin models present the classical fold of chymotrypsin-like enzymes, with two juxtaposed β-barrel domains and the catalytic residues bridging the barrels (Fig. 5) . The relative orientations of the secondary-structure elements are conserved between the models and the templates, with an alpha carbon root-mean-square deviation (Cα rmsd) below 2.3 Å. The md simulation allows refining of the loop conformations at the binding interface, exemplified by the tip of HpCh2A loop 35 achieving a 10-Å movement from the starting conformation. After an initial jump, this loop remains stable for the last 45 ns, with an average Cα rmsd to the final conformation of 0.38 Å. The chymotrypsin/NaPI interface is stable in both complexes as, after superimposition of the secondarystructure elements of the initial and final md conformations, the NaPI residues at the interface have an α-carbon located at less than 2 Å from their initial position. The molecular models of the H. punctigera chymotrypsins predict several atomic interactions that could explain the contribution of Arg192 and loop 35 to binding of the 6-kDa inhibitor, C1 (Fig. 5 ). The HpCh5 model shows that Arg192 has several van der Waals contacts with the C1 disulfide bridge 4-41 and forms hydrogen bonds with the side-chain oxygen of Asp6 on C1 as well as the backbone oxygen of C1 Cys4. Additionally, the Arg192 guanidinium group is partially solvated and is involved in watermediated hydrogen bonds with C1 Tyr16. Conversely, the HpCh2A Gln192 forms limited van der Waals interactions with Leu39.
At the molecular interface of the HpCh2A/C1 model, loop 35 folds into a stable β-hairpin and is associated with a large hydrophobic patch on the chymotrypsin surface. Phe35B, in loop 35 of HpCh2A, makes hydrophobic contacts with Pro43 of the C1 inhibitor (Fig. 5) . In addition, C1 Arg2 forms hydrogen bonds with the backbone of HpCh2A at amino acid 38. Conversely, HpCh5 loop 35 does not form a β-hairpin and does not present any direct interaction with C1 (Fig. 5) . The amino acids at positions 34, 35, 35A, and 35B are not part of the PI interface, but may help stabilize the conformation of HpCh5 loop 35 (Fig. 5 ).
Discussion
It is well known that insects produce PI-resistant trypsins and chymotrypsins in response to the consumption of PIs (5, 6, (17) (18) (19) (20) , but the molecular features that contribute to PI resistance have not been well characterized. In this study, we use mutagenesis and molecular modeling to determine the features responsible for the resistance of a digestive chymotrypsin from H. punctigera to C1, a 6-kDa chymotrypsin inhibitor derived from the multiple-domain proteinase inhibitor (NaPI) from Nicotiana alata.
Two gut chymotrypsins, with different binding affinities to C1, were purified to homogeneity and the corresponding cDNAs cloned. The isolation procedure began with the binding of NaPIsusceptible proteases to immobilized NaPI followed by capture of the unbound NaPI-resistant proteases on immobilized potato type I inhibitor. The proteases from both columns were eluted, and sequencing revealed the presence of a single protein in the eluate from each column. Chymotrypsins from other lepidopteran species have been purified using techniques such as ion-exchange (21) and affinity chromatography (22, 23) . Furthermore, PI-resistant chymotrypsins have been reported in Helicoverpa zea and Agrotis ipsilon (18) and H. armigera (24) but, to our knowledge, no PI-resistant chymotrypsins have been purified to homogeneity. Volpicella and coworkers (20) found that feeding the soybean kunitz trypsin inhibitor (SKTI) to H. zea larvae increased the proportion of gut chymotrypsin activity resistant to SKTI. They used a mustard trypsin inhibitor affinity column to enrich for the PI-resistant enzymes and obtained two chymotrypsins and one trypsin. The molecular basis of resistance to SKTI was not described but, interestingly, one of the potentially SKTI-resistant chymotrypsins (GenBank accession no. Y12287) shared 97% sequence identity with the NaPI-susceptible chymotrypsin, HpCh2A. The amino acids required for resistance to NaPI were not present in the SKTIresistant chymotrypsin, suggesting a different mode of resistance.
Comparison of the predicted PI-binding sites of the NaPIresistant and the NaPI-susceptible chymotrypsins revealed a number of significant amino acid changes that were targeted for mutation. We first focused on Arg192 as a promising PI resistance candidate because charged residues at this position play an important role in mediating binding interactions with proteinase inhibitors. One example is a Q192E mutation in factor Xa which results in poorer inhibition by BPTI and tissue factor pathway inhibitor (25) , whereas an E192Q conversion in activated protein C greatly improved binding of several proteinaceous inhibitors (26) . Human brain trypsin IV is highly resistant to PIs, and this resistance has been attributed to arginine 193 (16, 27) . Surprisingly, we found that the Arg192Gln substitution created an enzyme more resistant to NaPI, suggesting that Arg192 is involved in the binding interaction with NaPI.
We then made additional chymotrypsin variants changing amino acids within and outside the predicted PI-binding domains. IC 50 determinations were performed using increasing concentrations of recombinant C1 as described. IC 50 values are an average ± SEM of three independent experiments. Fig. 4 . Inhibition of chymotrypsin variants. Recombinant chymotrypsins (100 ng) were preincubated for 10 min with increasing concentrations of C1 inhibitor before addition of the substrate succ-AAPF-pNa as described in Materials and Methods. The residual activity was measured at 405 nm and plotted as a percentage of the control. Error bars are the SE of the average of three independent experiments performed in duplicate. Substitution of loop 35 converted the NaPI-susceptible chymotrypsin to NaPI-resistant.
The amino acids outside the reported PI-binding domains were not involved in PI resistance ( Table 1) . Substitution of four amino acids (LANF) in loop 35 of HpCh2A with the amino acids VIDL from HpCh5 converted the NaPI-susceptible chymotrypsin to an NaPI-resistant chymotrypsin. Interestingly, loop 35 is also involved in modulating the interaction between tissue-type plasminogen activator and its specific inhibitor (28) .
Further investigation into the contribution of each of the amino acids VIDL from the NaPI-resistant chymotrypsin revealed that Leu37 cannot make critical binding interactions with the C1 inhibitor. We also show that StPin1A is an excellent inhibitor of both the NaPI-resistant and -susceptible chymotrypsins. The improved binding of StPin1A to the chymotrypsins might, in part, be attributed to the enhanced flexibility of the reactive site loop due to the lack of flanking disulfide bonds (29) such as those that constrain the reactive site loop of NaPI (30) . This flexibility in the reactive site loop may lead to more contacts between enzyme and inhibitor, as is the case with the pin I inhibitor CI-2, which makes substantially more contacts with subtilisin (31) than the pin II inhibitor, PCI-1, does with proteinase B (32) . There have been other attempts to understand the molecular basis of PI resistance in insect proteinases. For example, a carboxypeptidase B from H. zea is resistant to inhibition by the potato carboxypeptidase inhibitor (PCI), whereas carboxypeptidase A is not. Analysis of the crystal structure revealed that a loop in the secondary binding site was positioned so that the active site of the enzyme was blocked, preventing PCI binding (33) . Volpicella and coworkers (34) suggested a functional difference in the secondary binding site of a trypsin from H. zea was responsible for resistance to SKTI, although the mechanism was not described. In contrast, the NaPI resistance mechanism in the H. punctigera chymotrypsin (HpCh5) is modulated by amino acids residing in the S1′ subsite.
We have characterized the molecular basis of resistance of an insect chymotrypsin to the plant proteinase inhibitor NaPI. Understanding how insects develop resistance to PIs is fundamental to the future rational design of PIs for the protection of agronomically important plants against insect pests. This knowledge will allow the development of a strategy to produce lepidopteranresistant transgenic plants that will incorporate multiple inhibitors with structural diversity that target different enzyme specificities.
Materials and Methods
Preparation of Proteinase Inhibitors for Inhibition Assays. Purification of NaPI from Nicotiana alata has been described previously (35, 36) . Recombinant chymotrypsin inhibitor domain C1 and StPin1A (GenBank accession no. FJ839694) were produced using the pHUE expression system (37) . The C1 and StPin1A inhibitors were amplified (primer sequences are shown in SI Text) and cloned into the pHUE vector. The expression, purification, and cleavage of the ubiquitin fusion proteins was performed as described previously (37) . The purified recombinant C1 and StPin1A inhibitors were concentrated by lyophilization and stored at −20°C. Working stocks of PIs were made in 10 mM ammonium bicarbonate (pH 7.8), 0.01% octyl-β-D-glucopyranoside (Roche) and protein concentrations were determined using the BCA protein assay kit (Pierce).
Proteinase Inhibitor Affinity Columns. The chymotrypsin inhibitor (C1) column consisted of bacterially expressed hexahistidine-tagged C1 bound to BD TALON metal affinity resin (BD Biosciences Clontech). C1 was cloned into the BamHI and HindIII sites of the pQE30 expression vector (Qiagen) in-frame with an Nterminal hexahistidine tag (primer sequences are shown in SI Text). The C1/ pQE30 construct was transformed into Escherichia coli strain M15 for expression. The C1 histidine fusion protein (6hisC1) was purified under denaturing conditions according to the manufacturer's instructions (Qiagen). Approximately 2 mg of purified 6hisC1 was bound to TALON resin under denaturing conditions (8 M urea, 50 mM Tris-HCl, pH 8). The urea was removed by washing the column with decreasing concentrations of urea (1 M urea increments). The potato type I inhibitor (pin I) column was prepared by binding 10 mg of pin I inhibitors to cyanogen bromide-activated Sepharose 4B (1 g; Sigma) according to the manufacturer's instructions. The crude preparation of pin I inhibitors from potatoes was kindly provided by Dr. Tony McGhee, Bureau of Sugar Experiment Station, Indooroopilly, QLD, Australia.
Purification and Analysis of NaPI-Susceptible and -Resistant Chymotrypsins. Eighty guts from late fourth-instar larvae were homogenized in 10 mL of extraction buffer (20 mM 3-cyclohexylamino-1-propanesulfonic acid pH 10, 350 mM NaCl) and then clarified by centrifugation (15,000 × g, 15 min, 4°C) and filtration (0.45 μM; Millipore). All affinity columns were equilibrated with 10 column volumes of extraction buffer before loading the gut extracts. The soluble gut extract (10 mL) was applied to a benzamidine-agarose column (2 mL; Sigma-Aldrich) to remove trypsins. The benzamidine-unbound material was loaded onto the 6hisC1 affinity column (2 mL) and the void fraction was collected and reloaded onto a pin I affinity column. C1-and pin I-bound proteins were eluted with 8 M urea, 50 mM Tris-HCl (pH 8.0; 10 mL). Proteins from various stages of purification (5-10 μg) were concentrated by trichloroacetic acid precipitation and dissolved in 0.2 M NaOH (10 μL) before separation on 12.5% (wt/vol) SDS/polyacrylamide gels and electroblotting onto Sequi-Blot PVDF membrane (Bio-Rad). N-terminal sequence was obtained by sequential Edman degradation using an automated protein-sequencing system (G1005A; Hewlett Packard).
Isolation of Gut RNA and Partial Chymotrypsin cDNAs. Whole gut (100 mg) was removed from late fourth-and early fifth-instar larvae that had been fed for 48 h on a haricot bean-based diet supplemented with 0.3% (wt/vol) soybean trypsin inhibitor (SBTI; Sigma-Aldrich). RNA was isolated using TRIzol reagent (1 mL; Invitrogen) and partial cDNAs were obtained using reversetranscriptase PCR (RT-PCR). The 5′ PCR primers (FwG1 and FwReschym) were designed based on the N-terminal sequence of the purified gut proteins and the 3′ primer (RvG4) was designed to the C-terminal conserved sequence (PAAF [225] [226] [227] [228] ) identified in the multiple sequence alignment of H. armigera chymotrypsin cDNAs (primer sequences are shown in SI Text).
Preparation of H. punctigera cDNA Library, Screening, and Sequence Alignments. Total RNA (1 mg) was prepared as described in the previous section, and mRNA was purified using a PolyATract mRNA Isolation System (Promega). The mRNA (5 μg) was used to construct a cDNA library with the Lambda ZAP-cDNA synthesis and packaging extracts (Stratagene). Fulllength cDNAs were obtained by screening the cDNA library with [α 32 P]dCTPlabeled PCR products. RT-PCR products and cDNAs were sequenced in both directions and sequences were edited using BioEdit v5.0.9.1 software (38) . Alignments were performed using Clustal W (39) . Sequence identity scores were determined using the Global optimal alignment program (GAP3) (40) .
Construction of Chymotrypsin Mutants. All chymotrypsin mutants were created using the splice-overlap extension (SOE) PCR method (41) . The mutants were constructed by substituting residues from the HpCh5 chymotrypsin (GenBank accession no. AY618895) sequence with the corresponding residues from the HpCh2A chymotrypsin (GenBank accession no. AY618891) sequence and vice versa. The complementary mutagenic oligonucleotide pairs were used in conjunction with either 5′Ch5bacFW and 3′Ch5bacRV or 5′ Ch2AbacFW and 3′Ch2AbacRV to produce the overlapping 5′ and 3′ ends encoding the full-length chymotrypsin cDNAs for SOE. The Ch5bacFW primer included the ER signal peptide sequence from the HpCh2A clone for subsequent secreted expression in the baculovirus system. The following chymotrypsin variants were created, and mutated residues are numbered according to Greer (42) Expression, Purification, and Activation of Recombinant Chymotrypsinogens. The full-length cDNAs of HpCh5 and HpCh2A chymotrypsinogens were cloned into the donor plasmid pFastBac (Invitrogen). During cloning, a hexahistidine tag was inserted between the ER signal sequence and the chymotrypsinogen activation peptide. All expression constructs were confirmed by sequencing. Cloning and expression were performed following the procedures outlined in the Bac-to-Bac expression manual (Invitrogen). Medium containing the secreted chymotrypsinogens was clarified by centrifugation at 72 h postinfection, adjusted to pH 7.5, and then put through 0.22-μm filters. His-tagged chymotrypsinogens were purified using TALON metal affinity resin (BD Biosciences Clontech) according to the manufacturer's instructions. Purified chymotrypsinogens were concentrated using an Amicon stirred cell using a membrane with a molecular weight cutoff of 5 kDa. Purified chymotrypsins were activated by proteolytic removal of the activation peptide using bovine trypsin-agarose (30°C for 1 h).
Inhibition Assay. Each purified recombinant chymotrypsin (100 ng) was preincubated with increasing concentrations of various inhibitors (rC1, StPin1A, and NaPI) in 50 mM CAPS buffer (pH 10) for 10 min at 22°C. The experiment was repeated three times using fresh batches of activated recombinant enzyme. Residual enzyme activity was measured using 1 mM succinyl-Ala-Ala-Pro-Phep-nitroanilide (Succ-AAPF-pNA; Sigma-Aldrich), and substrate hydrolysis was recorded at 405 nm using a Spectramax 250 plate reader (Molecular Devices).
Structural Modeling. The amino acid sequences of the NaPI-susceptible (HpCh2A) and NaPI-resistant (HpCh5) chymotrypsins and the C1 inhibitor from N. alata were used to construct structural models by homology, using Modeler 9v5 (43) . Five crystallographic structures were selected as templates based on their sequence identity and their resolution: Protein Data Bank (PDB) ID code 1FY5 (fungus Fusarium oxysporum trypsin, at 0.85-Å resolution), PDB ID code 1EQ9 (ant Solenopsis invicta chymotrypsin, at 1.7 Å), PDB ID code 2HLC (fly larvae Hypoderma lineatum collagenase, at 1.7 Å), PDB ID code 1T7C (bovine Bos taurus chymotrypsin complexed with BPTI, at 1.85 Å), and PDB ID code 1ELT (salmon Salmo salar elastase, at 1.61 Å). The C1 structure has been solved previously by NMR (PDB ID code 1FYB) (30) , and the complex between Streptomyces griseus proteinase B (sharing 27% identity with HpCh2A and 25% identity with HpCh5) and the chymotrypsin inhibitor-1 from Russet Burbank potato (PDB ID code 4SGB) were used to orient the complexes between the insect chymotrypsins and C1. A multiple alignment was generated using Clustal W (39) between the five template sequences, 37 close homologous sequences retrieved from UniProtKB/Swiss-Prot (10), and the insect chymotrypsins HpCh2A and HpCh5. The ability of each individual template to model the nonstructurally conserved regions was investigated by checking the consistency between interactions present in the structure and the previously obtained alignment. Modeler 9v5 (43) was used to compute 50 models for each receptor. Chymotrypsin loop 35, comprising seven residues (see Fig.  1 ), was modeled ab initio using Loopy (44) . The models were then subjected to 50 ns of molecular dynamics simulation, at 293 K, with explicit water representation (∼16,000 water molecules). The final complex conformation was subjected to a simulated annealing protocol (100 ps) and then minimized using a steepest descent algorithm. Molecular dynamic simulations, simulated annealing, and minimizations were performed with GROMACS 3.3.1 (45) .
